お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:目まい:世界の臨床試験レビュー (2020年後期)
市場調査レポート
商品コード
975166

目まい:世界の臨床試験レビュー (2020年後期)

Vertigo Disease - Global Clinical Trials Review, H2, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 104 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.72円
目まい:世界の臨床試験レビュー (2020年後期)
出版日: 2020年12月01日
発行: GlobalData
ページ情報: 英文 104 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界における目まいの臨床試験に関する主要データを提供しており、主要国における試験数と平均登録数、地域、国 (G7およびE7) 、フェーズ、試験ステータス、エンドポイントステータス、およびスポンサータイプ別による臨床試験の範囲、有望薬に関する情報を提供しています。

注:レポートの特定のセクションは、示された疾患のデータの可用性と関連性に基づいて削除または変更される場合があります。

目次

目次

テーブルのリスト

図のリスト

  • レポートガイダンス
  • GlobalData の臨床試験調査範囲
  • 臨床試験:地域別
  • 臨床試験数と平均登録数:国別
  • アジア太平洋において臨床試験に貢献している上位5か国
  • 欧州において臨床試験に貢献している上位5か国
  • 北米において臨床試験に貢献している上位の国
  • 中東・アフリカにおいて臨床試験に貢献している上位国
  • 中南米において臨床試験に貢献している上位国
  • G7諸国における臨床試験:耳鼻咽喉疾患の臨床試験に対する目まいの割合
  • G7諸国における臨床試験:フェーズ別
  • G7諸国における臨床試験:治験ステータス別
  • E7諸国における臨床試験:耳鼻咽喉疾患の臨床試験に対する目まいの割合
  • E7諸国における臨床試験:フェーズ別
  • E7諸国における臨床試験:治験ステータス別
  • 臨床試験:フェーズ別
  • 進行中の臨床試験:フェーズ別
  • 臨床試験:治験ステータス別
  • 臨床試験:エンドポイントステータス
  • 一定期間にわたって募集された被験者
  • 臨床試験:スポンサータイプ別
  • 著名なスポンサー
  • 目まい治療薬の臨床試験に参加している主要企業
  • 有望な薬剤
  • 臨床試験プロファイルのスナップショット

付録

  • 略語
  • 定義
  • 調査手法
  • 2次調査
  • GlobalDataについて
  • お問い合わせ
  • ソース
図表

List of Tables

List of Tables

  • Vertigo Therapeutics, Global, Clinical Trials by Region, 2020*
  • Vertigo Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Vertigo Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Vertigo Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Vertigo Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Vertigo Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Vertigo Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2020*
  • Vertigo Therapeutics Clinical Trials, Central and South America, Top Countries, 2020*
  • Proportion of Vertigo to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2020*
  • Vertigo Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Vertigo Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Vertigo to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2020*
  • Vertigo Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Vertigo Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Vertigo Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Vertigo Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Vertigo Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Vertigo Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Vertigo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Vertigo Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Vertigo Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Vertigo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Vertigo Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Vertigo Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Vertigo Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Vertigo Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Vertigo Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Vertigo Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Vertigo Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Vertigo Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2020*
  • Proportion of Vertigo to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2020*
  • Vertigo Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Vertigo Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Vertigo to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2020*
  • Vertigo Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Vertigo Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Vertigo Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Vertigo Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Vertigo Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Vertigo Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Vertigo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Vertigo Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Vertigo Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Vertigo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Vertigo Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology
目次
Product Code: GDHC6524CTIDB

GlobalData's clinical trial report, "Vertigo Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Vertigo Clinical trials scenario. This report provides top line data relating to the clinical trials on Vertigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Vertigo to Ear Nose Throat Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Vertigo to Ear Nose Throat Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Vertigo Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.